News Search

09.04.2018 | Other

Allergan Announces Appointment of New Canadian Vice President and Country Manager Tracey Ramsay

Tracey’s leadership will support the future of the Allergan Canadian business focusing on people, patients and customers. Tracey has a multi-disciplinary background with experience in branded pharmaceuticals, consumer health care, and established products. Tracey’s appointment is a strategic fit for the Canadian organization.

Tracey is an accomplished pharmaceutical commercial leader and corporate executive with over 20 years of experience. She has lived and worked in Canada, the United States, and England in various roles with Johnson & Johnson, Takeda, Optimer and Sanofi. Her most recent position at Sanofi was Head of the North American General Medicine and Established Products Business Unit based in Cambridge, MA.

“I know our success is powered by our colleagues’ hard work.  I'm truly honoured to work with the dedicated Allergan Canada team to help our innovative, bold organization meet its patient-centric goals,” said Tracey Ramsay as Vice President and Country Manager for Canada. “With Allergan’s strong leadership in vital therapeutic areas such as Eyecare, GI, Neuroscience and Medical Aesthetics, I am excited to help this organization have an even greater impact on Canada’s health care system through the development of enhanced partnerships and new product offerings to best support patients, their families, and our healthcare professionals.”

Tracey holds a Bachelor of Science from Queen's University in Kingston, Ontario and a MBA from Dalhousie University in Halifax, Nova Scotia.

About Allergan plc

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical leader. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.

Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry.

Allergan’s success is powered by our global colleagues’ commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.

With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.

For more information, visit Allergan’s website at